Open Access 15-02-2025 | Prostate Cancer | REVIEW
The Impact of Diet and Nutrition on Prostate Cancer – Food for Thought?
Published in: Current Oncology Reports
Login to get accessPlease log in to get access to this content
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMedCrossRef
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMedCrossRef
2.
go back to reference Abrams DI. An integrative approach to prostate cancer. J Alternat Complement Med. 2018;24(9):872–80.CrossRef
Abrams DI. An integrative approach to prostate cancer. J Alternat Complement Med. 2018;24(9):872–80.CrossRef
3.
go back to reference Matsushita M, Fujita K, Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci. 2020;21:1447.PubMedPubMedCentralCrossRef
Matsushita M, Fujita K, Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci. 2020;21:1447.PubMedPubMedCentralCrossRef
4.
go back to reference Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.PubMedCrossRef
Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.PubMedCrossRef
5.
go back to reference Peisch SF, Van Blarigan EL, Chan JM, et al. Prostate Cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017;35:867–74.PubMedCrossRef
Peisch SF, Van Blarigan EL, Chan JM, et al. Prostate Cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017;35:867–74.PubMedCrossRef
6.
go back to reference Liss MA, Al-Bayati O, Gelford J, et al. Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study. Prostate Cancer Prostatic Dis. 2019;22:244–51.PubMedCrossRef
Liss MA, Al-Bayati O, Gelford J, et al. Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study. Prostate Cancer Prostatic Dis. 2019;22:244–51.PubMedCrossRef
7.
go back to reference De Carvalho C, Caramujo MJ. The various roles of fatty acids. Molecules. 2018;23:2583.PubMedPubMedCentralCrossRef
De Carvalho C, Caramujo MJ. The various roles of fatty acids. Molecules. 2018;23:2583.PubMedPubMedCentralCrossRef
8.
go back to reference DiPasquale MG. The essentials of essential fatty acids. J Dietary Suppl. 2009;6(2):143–61.CrossRef
DiPasquale MG. The essentials of essential fatty acids. J Dietary Suppl. 2009;6(2):143–61.CrossRef
9.
go back to reference Los DA, Murata N. Structure and expression of fatty acid desaturases. Biochem Biophys Acta. 1998;1394(1):3–15.PubMedCrossRef
Los DA, Murata N. Structure and expression of fatty acid desaturases. Biochem Biophys Acta. 1998;1394(1):3–15.PubMedCrossRef
10.
go back to reference Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacotherapy. 2002;56:365–79.CrossRef
Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacotherapy. 2002;56:365–79.CrossRef
11.
go back to reference Berquin IM, Min Y, Wu R, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Investig. 2007;117:1866–75.PubMedPubMedCentralCrossRef
Berquin IM, Min Y, Wu R, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Investig. 2007;117:1866–75.PubMedPubMedCentralCrossRef
12.
go back to reference Narita S, Nara T, Sato H, et al. Research evidence on high-fat diet-induced prostate cancer development and progression. J Clin Med. 2019;8:597.PubMedPubMedCentralCrossRef
Narita S, Nara T, Sato H, et al. Research evidence on high-fat diet-induced prostate cancer development and progression. J Clin Med. 2019;8:597.PubMedPubMedCentralCrossRef
13.
go back to reference Fleshner N, Bagnell S, Klotz L, et al. Dietary fat and prostate cancer. J Urol. 2004;171:S19-24.PubMedCrossRef
Fleshner N, Bagnell S, Klotz L, et al. Dietary fat and prostate cancer. J Urol. 2004;171:S19-24.PubMedCrossRef
14.
go back to reference Scaglia N, Frontini-Lopez YR, Zadra G. Prostate Cancer Progression: As a matter of fats. Front Oncol. 2021;11:719865.PubMedPubMedCentralCrossRef
Scaglia N, Frontini-Lopez YR, Zadra G. Prostate Cancer Progression: As a matter of fats. Front Oncol. 2021;11:719865.PubMedPubMedCentralCrossRef
15.
go back to reference Mozaffarian D, Cao H, King IB, et al. Trans-palmitoleic acid, metabolic risk factors, and new onset of diabetes in US adults: A cohort study. Ann Intern Med. 2010;153(12):790–9.PubMedPubMedCentralCrossRef
Mozaffarian D, Cao H, King IB, et al. Trans-palmitoleic acid, metabolic risk factors, and new onset of diabetes in US adults: A cohort study. Ann Intern Med. 2010;153(12):790–9.PubMedPubMedCentralCrossRef
16.
go back to reference Aronson WJ, Barnard RJ, Freedland SJ, et al. Growth inhibitory effect of low fat diet on prostate cancer cells: Results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol. 2010;183:345–50.PubMedPubMedCentralCrossRef
Aronson WJ, Barnard RJ, Freedland SJ, et al. Growth inhibitory effect of low fat diet on prostate cancer cells: Results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol. 2010;183:345–50.PubMedPubMedCentralCrossRef
17.
go back to reference Ngo TH, Barnard RJ, Cohen P, et al. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clin Cancer Res. 2003;9:2734–43.PubMed
Ngo TH, Barnard RJ, Cohen P, et al. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clin Cancer Res. 2003;9:2734–43.PubMed
18.
go back to reference Kobayashi N, Barnard RJ, Said J, et al. Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. Can Res. 2008;68:3066–73.CrossRef
Kobayashi N, Barnard RJ, Said J, et al. Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. Can Res. 2008;68:3066–73.CrossRef
19.
go back to reference Ma RWL, Chapman K. A systematic review of the effect of diet on prostate cancer prevention and treatment. J Hum Nutr Diet. 2009;22:187–99.PubMedCrossRef
Ma RWL, Chapman K. A systematic review of the effect of diet on prostate cancer prevention and treatment. J Hum Nutr Diet. 2009;22:187–99.PubMedCrossRef
20.
go back to reference Agalliu I, Kirsh VA, Kreiger, et al. Oxidative balance score and risk of prostate cancer: results from a cohort study. Cancer Epidemiology. 2011;35:353–61.PubMedCrossRef
Agalliu I, Kirsh VA, Kreiger, et al. Oxidative balance score and risk of prostate cancer: results from a cohort study. Cancer Epidemiology. 2011;35:353–61.PubMedCrossRef
21.
go back to reference Shankar E, Vykhovanets OV, Maclennan GT, et al. High-fat diet activates proinflammatory response in the prostate through association of Stat-3 and NF-kappa B. Prostate. 2012;72:233–43.PubMedCrossRef
Shankar E, Vykhovanets OV, Maclennan GT, et al. High-fat diet activates proinflammatory response in the prostate through association of Stat-3 and NF-kappa B. Prostate. 2012;72:233–43.PubMedCrossRef
22.
go back to reference Ngo TH, Barnard RJ, Anton T, et al. Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Can Res. 2004;64:1252–4.CrossRef
Ngo TH, Barnard RJ, Anton T, et al. Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Can Res. 2004;64:1252–4.CrossRef
23.
go back to reference Chavarro JE, Stampfer MJ, Li H, et al. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomark Prev. 2007;16(7):1364–70.CrossRef
Chavarro JE, Stampfer MJ, Li H, et al. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomark Prev. 2007;16(7):1364–70.CrossRef
24.
go back to reference Augustsson K, Michaud DS, Rimm EB, et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomark Prev. 2003;12:64–7.
Augustsson K, Michaud DS, Rimm EB, et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomark Prev. 2003;12:64–7.
25.
go back to reference Di Sebastiano KM, Mourtzakis M. The role of dietary fat throughout the prostate cancer trajectory. Nutrients (2014); 6095–6109
Di Sebastiano KM, Mourtzakis M. The role of dietary fat throughout the prostate cancer trajectory. Nutrients (2014); 6095–6109
26.
go back to reference Said MM, Hassan NS, Schlicht MJ, et al. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia. J Toxicol Environ Health. 2015;78:453–65.CrossRef
Said MM, Hassan NS, Schlicht MJ, et al. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia. J Toxicol Environ Health. 2015;78:453–65.CrossRef
27.
go back to reference Hakimi M, Shiari R, Shirkavand A, et al. Expression of apoptotic genes induced by flaxseed extract in human prostate cancer cell line. Journal of Medicinal Plants. 2024;23(89):57–67.CrossRef
Hakimi M, Shiari R, Shirkavand A, et al. Expression of apoptotic genes induced by flaxseed extract in human prostate cancer cell line. Journal of Medicinal Plants. 2024;23(89):57–67.CrossRef
28.
go back to reference Demark-Wahnefried W, Polascik TJ, George SL, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer cell proliferation rates in men pre-surgery. Cancer Epidemiol Biomark Prev. 2008;17:3577–87.CrossRef
Demark-Wahnefried W, Polascik TJ, George SL, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer cell proliferation rates in men pre-surgery. Cancer Epidemiol Biomark Prev. 2008;17:3577–87.CrossRef
29.
go back to reference Lin X, Gingrich JR, Bao W, et al. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology. 2002;60(5):919–24.PubMedCrossRef
Lin X, Gingrich JR, Bao W, et al. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology. 2002;60(5):919–24.PubMedCrossRef
30.
go back to reference Azrad M, Vollmer RT, Madden J, et al. Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer. J Med Food. 2013;16(4):357–60.PubMedPubMedCentralCrossRef
Azrad M, Vollmer RT, Madden J, et al. Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer. J Med Food. 2013;16(4):357–60.PubMedPubMedCentralCrossRef
31.
go back to reference Stattin P, Bylund A, Biessy C, et al. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control. 2004;15:1095–102.PubMedCrossRef
Stattin P, Bylund A, Biessy C, et al. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control. 2004;15:1095–102.PubMedCrossRef
32.
go back to reference Hedelin M, Klint A, Chang ET, et al. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study. Cancer Causes Control. 2006;17(2):169–80.PubMedCrossRef
Hedelin M, Klint A, Chang ET, et al. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study. Cancer Causes Control. 2006;17(2):169–80.PubMedCrossRef
33.
go back to reference Bylund A, Lundin E, Zhang JX, et al. Randomised controlled short-term intervention pilot study on rye bread in prostate cancer. Eur J Cancer Prev. 2003;12:407–15.PubMedCrossRef
Bylund A, Lundin E, Zhang JX, et al. Randomised controlled short-term intervention pilot study on rye bread in prostate cancer. Eur J Cancer Prev. 2003;12:407–15.PubMedCrossRef
34.
go back to reference Mao Y, Tie Y, Du J. Association between dietary protein intake and prostate cancer risk: evidence from a meta-analysis. World J Surg Oncol. 2018;16:152.PubMedPubMedCentralCrossRef
Mao Y, Tie Y, Du J. Association between dietary protein intake and prostate cancer risk: evidence from a meta-analysis. World J Surg Oncol. 2018;16:152.PubMedPubMedCentralCrossRef
35.
go back to reference Delimaris I. Adverse effects associated with protein intake above the recommended dietary allowance for adults. ISRN Nutrition. 2013;2013:126929.PubMedPubMedCentralCrossRef
Delimaris I. Adverse effects associated with protein intake above the recommended dietary allowance for adults. ISRN Nutrition. 2013;2013:126929.PubMedPubMedCentralCrossRef
36.
go back to reference Alzahrani MA, Ahmad MS, Alkhamees M, et al. Dietary protein intake and prostate cancer risk in adults: A systematic review and dose-response meta-analysis of prospective cohort studies. Complement Ther Med. 2022;70:102851.PubMedCrossRef
Alzahrani MA, Ahmad MS, Alkhamees M, et al. Dietary protein intake and prostate cancer risk in adults: A systematic review and dose-response meta-analysis of prospective cohort studies. Complement Ther Med. 2022;70:102851.PubMedCrossRef
37.
go back to reference John EM, Stern MC, Sinha R, et al. Meat consumption, cooking practices, meat mutagens and risk of prostate cancer. Nutr Cancer. 2011;63(4):525–37.PubMedPubMedCentralCrossRef
John EM, Stern MC, Sinha R, et al. Meat consumption, cooking practices, meat mutagens and risk of prostate cancer. Nutr Cancer. 2011;63(4):525–37.PubMedPubMedCentralCrossRef
38.
go back to reference Oczkowski M, Dziendzikowska K, Pasternak-Winiarska A, et al. Dietary factors and prostate cancer development, progression, and reduction. Nutrients. 2021;13:496.PubMedPubMedCentralCrossRef
Oczkowski M, Dziendzikowska K, Pasternak-Winiarska A, et al. Dietary factors and prostate cancer development, progression, and reduction. Nutrients. 2021;13:496.PubMedPubMedCentralCrossRef
39.
go back to reference Lin PH, Aronson W, Freedland SJ. Nutrition, dietary interventions and prostate cancer: The latest evidence. BMC Med. 2015;13:3.PubMedPubMedCentralCrossRef
Lin PH, Aronson W, Freedland SJ. Nutrition, dietary interventions and prostate cancer: The latest evidence. BMC Med. 2015;13:3.PubMedPubMedCentralCrossRef
40.
go back to reference De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate cancer carcinogenesis. Nat Rev Cancer. 2007;7:256–69.PubMedPubMedCentralCrossRef
De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate cancer carcinogenesis. Nat Rev Cancer. 2007;7:256–69.PubMedPubMedCentralCrossRef
41.
go back to reference Kaiser A, Haskins C, Siddiqui MM, et al. The evolving role of diet in prostate cancer risk and progression. Curr Opin Oncol. 2019;31(3):222–9.PubMedPubMedCentralCrossRef
Kaiser A, Haskins C, Siddiqui MM, et al. The evolving role of diet in prostate cancer risk and progression. Curr Opin Oncol. 2019;31(3):222–9.PubMedPubMedCentralCrossRef
42.
go back to reference Levine MM, Suarez JA, Brandhorst S, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cellular Metabolism. 2014;19(3):407–17.CrossRef
Levine MM, Suarez JA, Brandhorst S, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cellular Metabolism. 2014;19(3):407–17.CrossRef
43.
go back to reference Song J, Chen C, He S, et al. Is there a non-linear relationship between dietary protein intake and prostate-specific antigen: proof from the national health and nutrition examination survey (2003–2010). Lipids Health Dis. 2020;19:82.PubMedPubMedCentralCrossRef
Song J, Chen C, He S, et al. Is there a non-linear relationship between dietary protein intake and prostate-specific antigen: proof from the national health and nutrition examination survey (2003–2010). Lipids Health Dis. 2020;19:82.PubMedPubMedCentralCrossRef
44.
go back to reference Braga-Basaria M, Dobs AS, Muller DC, et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen deprivation therapy. J Clin Oncol. 2006;24:3979–83.PubMedCrossRef
Braga-Basaria M, Dobs AS, Muller DC, et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen deprivation therapy. J Clin Oncol. 2006;24:3979–83.PubMedCrossRef
45.
go back to reference Outzen M, Tjønneland A, Christense J, et al. Fish consumption and prostate cancer risk and mortality in a Danish cohort study. Eur J Cancer Prev. 2018;27:355–60.PubMedCrossRef
Outzen M, Tjønneland A, Christense J, et al. Fish consumption and prostate cancer risk and mortality in a Danish cohort study. Eur J Cancer Prev. 2018;27:355–60.PubMedCrossRef
46.
go back to reference Aucoin M, Cooley K, Knee C, et al. Fish-derived Omega-3 Fatty Acids and prostate cancer: a systematic review. Integr Cancer Ther. 2017;16(1):32–62.PubMedCrossRef
Aucoin M, Cooley K, Knee C, et al. Fish-derived Omega-3 Fatty Acids and prostate cancer: a systematic review. Integr Cancer Ther. 2017;16(1):32–62.PubMedCrossRef
47.
go back to reference Eser PO, Vanden Heuvel JP, Araujo J, et al. Marine- and plant-derived omega-3 fatty acids differentially regulate prostate cancer cell proliferation. Molecular Clinical Oncology. 2013;1:444–52.PubMedPubMedCentralCrossRef
Eser PO, Vanden Heuvel JP, Araujo J, et al. Marine- and plant-derived omega-3 fatty acids differentially regulate prostate cancer cell proliferation. Molecular Clinical Oncology. 2013;1:444–52.PubMedPubMedCentralCrossRef
48.
go back to reference Torfadottir JE, Valdimarsdottir UA, Mucci LA, et al. Consumption of fish products across the lifespan and prostate cancer risk. PLoS ONE. 2013;8(4):e59799.PubMedPubMedCentralCrossRef
Torfadottir JE, Valdimarsdottir UA, Mucci LA, et al. Consumption of fish products across the lifespan and prostate cancer risk. PLoS ONE. 2013;8(4):e59799.PubMedPubMedCentralCrossRef
49.
go back to reference Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223–33.PubMedCrossRef
Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223–33.PubMedCrossRef
50.
go back to reference Eshaghian N, Heiderzadeh-Esfahani N, Akbari H et al. Fish consumption and risk of prostate cancer or its mortality: an updated systematic review and dose-response meta-analysis of prospective cohort studies. Front Nutrition (2023); 10.1221029
Eshaghian N, Heiderzadeh-Esfahani N, Akbari H et al. Fish consumption and risk of prostate cancer or its mortality: an updated systematic review and dose-response meta-analysis of prospective cohort studies. Front Nutrition (2023); 10.1221029
51.
go back to reference Allen NE, Key TJ, Appleby PN, et al. Animal foods, protein, calcium and prostate cancer risk. The European prospective investigation into cancer and nutrition. British J Cancer. 2008;98:1574–81.CrossRef
Allen NE, Key TJ, Appleby PN, et al. Animal foods, protein, calcium and prostate cancer risk. The European prospective investigation into cancer and nutrition. British J Cancer. 2008;98:1574–81.CrossRef
52.
go back to reference Richman EL, Stampfer MJ, Paciorek A, et al. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91:712–21.PubMedCrossRef
Richman EL, Stampfer MJ, Paciorek A, et al. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91:712–21.PubMedCrossRef
53.
go back to reference Pham TM, Fujino Y, Kubo T, et al. Fish intake and the risk of fatal prostate cancer: findings from a cohort study in Japan. Public Health Nutr. 2009;12(609):613.
Pham TM, Fujino Y, Kubo T, et al. Fish intake and the risk of fatal prostate cancer: findings from a cohort study in Japan. Public Health Nutr. 2009;12(609):613.
54.
go back to reference Dai Y. Bai Y and Zhang X: Fish consumption and prostate cancer risk: a meta-analysis of 37 studies. Int J Clin Exp Med. 2017;10(7):9891–900.
Dai Y. Bai Y and Zhang X: Fish consumption and prostate cancer risk: a meta-analysis of 37 studies. Int J Clin Exp Med. 2017;10(7):9891–900.
55.
go back to reference Khatun P, Saha P, Islam MZ, et al. The reality of the use of growth hormones in fish (Rui (Labeo rohita), Catla (Catla catla), and Monosex Tilapia (Oreochromis niloticus) production. Curr Res Food Sci. 2024;8:100709.PubMedPubMedCentralCrossRef
Khatun P, Saha P, Islam MZ, et al. The reality of the use of growth hormones in fish (Rui (Labeo rohita), Catla (Catla catla), and Monosex Tilapia (Oreochromis niloticus) production. Curr Res Food Sci. 2024;8:100709.PubMedPubMedCentralCrossRef
56.
go back to reference Hatha M, Vivekanandhan AA, Joice JG, et al. Antibiotic resistance pattern of motile aeromonads form farm raised fresh water fish. Int J Food Microbiol. 2005;98(2):131–4.PubMedCrossRef
Hatha M, Vivekanandhan AA, Joice JG, et al. Antibiotic resistance pattern of motile aeromonads form farm raised fresh water fish. Int J Food Microbiol. 2005;98(2):131–4.PubMedCrossRef
57.
go back to reference Stewart M, Phillips NR, Olsen G, et al. Organochlorines and heavy metals in wild caught food as a potential human health risk to the indigenous Māori population of South Canterbury. New Zealand Sci Total Environ. 2011;409:2029–39.PubMedCrossRef
Stewart M, Phillips NR, Olsen G, et al. Organochlorines and heavy metals in wild caught food as a potential human health risk to the indigenous Māori population of South Canterbury. New Zealand Sci Total Environ. 2011;409:2029–39.PubMedCrossRef
58.
go back to reference Storelli MM, Barone G, Cuttone G, et al. Occurrence of toxic metals (Hg, Cd and Pb) in fresh and canned tuna: Public health implications. Food Chem Toxicol. 2010;48(11):3167–70.PubMedCrossRef
Storelli MM, Barone G, Cuttone G, et al. Occurrence of toxic metals (Hg, Cd and Pb) in fresh and canned tuna: Public health implications. Food Chem Toxicol. 2010;48(11):3167–70.PubMedCrossRef
59.
go back to reference Fattore M, Russo G, Barbato F, et al. Monitoring of bisphenols in canned tuna from Italian markets. Food Chem Toxicol. 2015;83:68–75.PubMedCrossRef
Fattore M, Russo G, Barbato F, et al. Monitoring of bisphenols in canned tuna from Italian markets. Food Chem Toxicol. 2015;83:68–75.PubMedCrossRef
60.
go back to reference Keum N, Lee DH, Marchand N, et al. Egg intake and cancers of the breast, ovary and prostate: a dose-response meta-analysis of prospective observational studies. Br J Nutr. 2015;114:1099–107.PubMedCrossRef
Keum N, Lee DH, Marchand N, et al. Egg intake and cancers of the breast, ovary and prostate: a dose-response meta-analysis of prospective observational studies. Br J Nutr. 2015;114:1099–107.PubMedCrossRef
61.
go back to reference Awwad HM, Geisel J, Obeid R. The role of choline in prostate cancer. Clin Biochem. 2012;45:1548–53.PubMedCrossRef
Awwad HM, Geisel J, Obeid R. The role of choline in prostate cancer. Clin Biochem. 2012;45:1548–53.PubMedCrossRef
62.
go back to reference Bosland MC, Mahmoud AM. Hormones and prostate carcinogenesis: androgens and estrogens. J Carcinogenesis. 2011;10:33.CrossRef
Bosland MC, Mahmoud AM. Hormones and prostate carcinogenesis: androgens and estrogens. J Carcinogenesis. 2011;10:33.CrossRef
63.
go back to reference Wilson KM, Mucci LA, Drake BF, et al. Meat, fish, poultry, and egg intake at diagnosis and risk of prostate cancer progression. Cancer Prev Res. 2016;9(12):933–41.CrossRef
Wilson KM, Mucci LA, Drake BF, et al. Meat, fish, poultry, and egg intake at diagnosis and risk of prostate cancer progression. Cancer Prev Res. 2016;9(12):933–41.CrossRef
64.
go back to reference Lopez-Plaza B, Bermejo LM, Santurino C, et al. Dairy product consumption and prostate cancer risk and mortality: An overview of systematic reviews and Meta-analyses. Adv Nutr. 2019;10:S212–23.PubMedPubMedCentralCrossRef
Lopez-Plaza B, Bermejo LM, Santurino C, et al. Dairy product consumption and prostate cancer risk and mortality: An overview of systematic reviews and Meta-analyses. Adv Nutr. 2019;10:S212–23.PubMedPubMedCentralCrossRef
65.
go back to reference Zhao Z, Wu D, Gao S, et al. The association between dairy products consumption and prostate cancer risk: a systematic review and meta-analysis. Br J Nutr. 2023;129:1714–31.PubMedCrossRef
Zhao Z, Wu D, Gao S, et al. The association between dairy products consumption and prostate cancer risk: a systematic review and meta-analysis. Br J Nutr. 2023;129:1714–31.PubMedCrossRef
66.
go back to reference Aune D, Navaro Rosenblatt DA, Chan D, et al. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr. 2015;101:87–117.PubMedCrossRef
Aune D, Navaro Rosenblatt DA, Chan D, et al. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr. 2015;101:87–117.PubMedCrossRef
67.
go back to reference Downer MK, Batista JL, Mucci LA, et al. Dairy intake in relation to prostate cancer survival. Int J Cancer. 2017;140:2060–9.PubMedCrossRef
Downer MK, Batista JL, Mucci LA, et al. Dairy intake in relation to prostate cancer survival. Int J Cancer. 2017;140:2060–9.PubMedCrossRef
68.
go back to reference Setlur SR, Mertz KD, Hoshida Y, et al. Estrogen-dependent signalling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst. 2008;100(11):815–25.PubMedCrossRef
Setlur SR, Mertz KD, Hoshida Y, et al. Estrogen-dependent signalling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst. 2008;100(11):815–25.PubMedCrossRef
69.
go back to reference Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005;8:804–10.CrossRef
Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005;8:804–10.CrossRef
70.
go back to reference Pendleton JM, Tan WW, Anai S, et al. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer. 2008;8:132–42.PubMedPubMedCentralCrossRef
Pendleton JM, Tan WW, Anai S, et al. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer. 2008;8:132–42.PubMedPubMedCentralCrossRef
71.
go back to reference Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men. A revisit of meta-analysis. American Journal of Clinical Nutrition. 2009;89:1155–63.PubMedCrossRef
Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men. A revisit of meta-analysis. American Journal of Clinical Nutrition. 2009;89:1155–63.PubMedCrossRef
72.
go back to reference Hwang YW, Kim SY, Jee SH, et al. Soy food consumption and risk of prostate cancer: A meta-analysis of observational studies. Nutrition Cancer. 2009;61:598–606.PubMedCrossRef
Hwang YW, Kim SY, Jee SH, et al. Soy food consumption and risk of prostate cancer: A meta-analysis of observational studies. Nutrition Cancer. 2009;61:598–606.PubMedCrossRef
73.
go back to reference Applegate CC, Rowles JL, Ranard KM, et al. Soy consumption and risk of prostate cancer An updated systematic review and meta-analysis. Nutrients. 2018;10:40.PubMedPubMedCentralCrossRef
Applegate CC, Rowles JL, Ranard KM, et al. Soy consumption and risk of prostate cancer An updated systematic review and meta-analysis. Nutrients. 2018;10:40.PubMedPubMedCentralCrossRef
74.
go back to reference Chen CH, Huang PH, Chu PC, et al. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression. J Biol Chem. 2011;286:9968–76.PubMedPubMedCentralCrossRef
Chen CH, Huang PH, Chu PC, et al. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression. J Biol Chem. 2011;286:9968–76.PubMedPubMedCentralCrossRef
75.
go back to reference Freedland SJ, Mavropoulos J, Wang A, et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2008;68:11–9.PubMedPubMedCentralCrossRef
Freedland SJ, Mavropoulos J, Wang A, et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2008;68:11–9.PubMedPubMedCentralCrossRef
76.
go back to reference Masko EM, Thomas JA, Antonelli JA, et al. Low-carbohydrate diets and prostate cancer: How low is low enough? Cancer Prev Res. 2010;3(9):1124–31.CrossRef
Masko EM, Thomas JA, Antonelli JA, et al. Low-carbohydrate diets and prostate cancer: How low is low enough? Cancer Prev Res. 2010;3(9):1124–31.CrossRef
77.
go back to reference Shikany JM, Flood AP, Kitahara CM, et al. Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the prostate, lung, colorectal and ovarian cancer screening trial (PLCO) cohort. Cancer Causes Control. 2011;22:995–1002.PubMedPubMedCentralCrossRef
Shikany JM, Flood AP, Kitahara CM, et al. Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the prostate, lung, colorectal and ovarian cancer screening trial (PLCO) cohort. Cancer Causes Control. 2011;22:995–1002.PubMedPubMedCentralCrossRef
78.
go back to reference Drake I, Sonestedt E, Gullberg B, et al. Dietary intakes of carbohydrates in relation to prostate cancer risk: A prospective study in the Malmö Diet and Cancer Cohort. Am J Clin Nutr. 2012;96:1409–18.PubMedCrossRef
Drake I, Sonestedt E, Gullberg B, et al. Dietary intakes of carbohydrates in relation to prostate cancer risk: A prospective study in the Malmö Diet and Cancer Cohort. Am J Clin Nutr. 2012;96:1409–18.PubMedCrossRef
79.
go back to reference Makarem N, Bandera EV, Lin Y, et al. Carbohydrate nutrition and risk of adiposity-related cancers. Results from the Framingham Offspring cohort (1999–2013). British Journal of Nutrition. 2017;117:1603–14.PubMedCrossRef
Makarem N, Bandera EV, Lin Y, et al. Carbohydrate nutrition and risk of adiposity-related cancers. Results from the Framingham Offspring cohort (1999–2013). British Journal of Nutrition. 2017;117:1603–14.PubMedCrossRef
80.
go back to reference Miles FL, Neuhouser ML, Zhang ZF. Concentrated sugars and incidence of prostate cancer in a prospective cohort. Br J Nutr. 2018;120:703–10.PubMedPubMedCentralCrossRef
Miles FL, Neuhouser ML, Zhang ZF. Concentrated sugars and incidence of prostate cancer in a prospective cohort. Br J Nutr. 2018;120:703–10.PubMedPubMedCentralCrossRef
81.
go back to reference Hardin J, Cheng I, Witte JS. Impact of consumption of vegetable, fruit, grain and high glycemic index foods on aggressive prostate cancer risk. Nutr Cancer. 2011;63:860–72.PubMedPubMedCentralCrossRef
Hardin J, Cheng I, Witte JS. Impact of consumption of vegetable, fruit, grain and high glycemic index foods on aggressive prostate cancer risk. Nutr Cancer. 2011;63:860–72.PubMedPubMedCentralCrossRef
82.
go back to reference Vidal A, Williams CD, Allott EH, et al. Carbohydrate intake, glycemic index and prostate cancer risk. Prostate. 2015;75:430–9.PubMedCrossRef
Vidal A, Williams CD, Allott EH, et al. Carbohydrate intake, glycemic index and prostate cancer risk. Prostate. 2015;75:430–9.PubMedCrossRef
83.
go back to reference Mondul AM, Weinstein SJ, Albanes D. Vitamins, metabolomics and prostate cancer. World J Urol. 2017;35:883–93.PubMedCrossRef
Mondul AM, Weinstein SJ, Albanes D. Vitamins, metabolomics and prostate cancer. World J Urol. 2017;35:883–93.PubMedCrossRef
84.
go back to reference Donkena KV, Karnes RJ, Young CYF. Vitamins and prostate cancer risk. Molecules. 2010;15:1762–83.PubMedPubMedCentralCrossRef
Donkena KV, Karnes RJ, Young CYF. Vitamins and prostate cancer risk. Molecules. 2010;15:1762–83.PubMedPubMedCentralCrossRef
85.
go back to reference Peehl DM, Feldman D. The role of vitamin D and retinoids in controlling prostate cancer progression. Endocrine Related Cancer. 2003;10(2):131–40.PubMedCrossRef
Peehl DM, Feldman D. The role of vitamin D and retinoids in controlling prostate cancer progression. Endocrine Related Cancer. 2003;10(2):131–40.PubMedCrossRef
86.
go back to reference The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England J Med (1994);330(15):1029-1035
The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England J Med (1994);330(15):1029-1035
87.
go back to reference Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J National Cancer Institute. 1996;88(21):1550–9.CrossRef
Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J National Cancer Institute. 1996;88(21):1550–9.CrossRef
88.
go back to reference Wang Y, Cui R, Xiao Y, et al. Effect of carotene and lycopene on the risk of prostate cancer: A systematic review and dose-dependent meta-analysis of observational studies. PLoS ONE. 2015;10(9):e0137427.PubMedPubMedCentralCrossRef
Wang Y, Cui R, Xiao Y, et al. Effect of carotene and lycopene on the risk of prostate cancer: A systematic review and dose-dependent meta-analysis of observational studies. PLoS ONE. 2015;10(9):e0137427.PubMedPubMedCentralCrossRef
89.
go back to reference Miles FL, Goodman PJ, Tangen C, et al. Interactions of the insulin-like growth factor axis and vitamin D in prostate cancer risk in the Prostate Cancer Prevention Trial. Nutrients. 2017;9:378.PubMedPubMedCentralCrossRef
Miles FL, Goodman PJ, Tangen C, et al. Interactions of the insulin-like growth factor axis and vitamin D in prostate cancer risk in the Prostate Cancer Prevention Trial. Nutrients. 2017;9:378.PubMedPubMedCentralCrossRef
90.
go back to reference Shui IM, Mucci KA, Kraft P, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012;104:690–9.PubMedPubMedCentralCrossRef
Shui IM, Mucci KA, Kraft P, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012;104:690–9.PubMedPubMedCentralCrossRef
91.
go back to reference Ahn J, Peters U, Albanes D, et al. Serum vitamin D concentration and prostate cancer risk: A nested case-control study. J Natl Cancer Inst. 2008;100:796–804.PubMedCrossRef
Ahn J, Peters U, Albanes D, et al. Serum vitamin D concentration and prostate cancer risk: A nested case-control study. J Natl Cancer Inst. 2008;100:796–804.PubMedCrossRef
92.
go back to reference Deschasaux M, Souberbielle JC, Latino-Martel P, et al. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk. Br J Nutr. 2016;115:305–14.PubMedCrossRef
Deschasaux M, Souberbielle JC, Latino-Martel P, et al. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk. Br J Nutr. 2016;115:305–14.PubMedCrossRef
93.
go back to reference Lippman SM, Klein EA, Goodman PJ, et al. Effects of Selenium and vitamin E on risk of prostate cancer and other cancers. The Selenium and Vitamin E Cancer Prevention trial (SELECT). JAMA. 2009;301(1):39–51.PubMedCrossRef
Lippman SM, Klein EA, Goodman PJ, et al. Effects of Selenium and vitamin E on risk of prostate cancer and other cancers. The Selenium and Vitamin E Cancer Prevention trial (SELECT). JAMA. 2009;301(1):39–51.PubMedCrossRef
94.
go back to reference Antwi SO, Steck SE, Zhang H, et al. Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer. Cancer Epidemiol. 2015;39:752–62.PubMedPubMedCentralCrossRef
Antwi SO, Steck SE, Zhang H, et al. Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer. Cancer Epidemiol. 2015;39:752–62.PubMedPubMedCentralCrossRef
95.
go back to reference Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes Health – AARP Diet and Health Study. J Natl Cancer Inst. 2007;99:754–64.PubMedCrossRef
Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes Health – AARP Diet and Health Study. J Natl Cancer Inst. 2007;99:754–64.PubMedCrossRef
96.
go back to reference Calle EE, Rodriguez C, Jacobs J, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002;94:2490–501.PubMedCrossRef
Calle EE, Rodriguez C, Jacobs J, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002;94:2490–501.PubMedCrossRef
97.
go back to reference Capiod T, Delongchamp NB, Pigat N, et al. Do dietary calcium and vitamin D matter in men with prostate cancer? Nat Rev. 2018;15:453–61.
Capiod T, Delongchamp NB, Pigat N, et al. Do dietary calcium and vitamin D matter in men with prostate cancer? Nat Rev. 2018;15:453–61.
98.
go back to reference Monjotin N, Amiot MJ, Fleurentin J, et al. Clinical evidence of the benefits of phytonutrients in human healthcare. Nutrients. 2022;14:1712.PubMedPubMedCentralCrossRef
Monjotin N, Amiot MJ, Fleurentin J, et al. Clinical evidence of the benefits of phytonutrients in human healthcare. Nutrients. 2022;14:1712.PubMedPubMedCentralCrossRef
99.
go back to reference Gupta C, Prakash D. Phytonutrients as therapeutic agents. J Complement Integr Med. 2014;11(3):151–69.PubMedCrossRef
Gupta C, Prakash D. Phytonutrients as therapeutic agents. J Complement Integr Med. 2014;11(3):151–69.PubMedCrossRef
100.
go back to reference Zuniga KB, Chan JM, Ryan CJ, et al. Diet and lifestyle considerations for patients with prostate cancer. Urol Oncol. 2020;38:105–17.PubMedCrossRef
Zuniga KB, Chan JM, Ryan CJ, et al. Diet and lifestyle considerations for patients with prostate cancer. Urol Oncol. 2020;38:105–17.PubMedCrossRef
101.
go back to reference Rowles JL, Ranard KM, Smith JW, et al. Increased dietary intake and circulating lycopene are associated with reduced prostate cancer risk: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2017;20:361–77.PubMedCrossRef
Rowles JL, Ranard KM, Smith JW, et al. Increased dietary intake and circulating lycopene are associated with reduced prostate cancer risk: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2017;20:361–77.PubMedCrossRef
102.
go back to reference Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era. J National Cancer Institute. 2014;106(2):djt430.CrossRef
Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era. J National Cancer Institute. 2014;106(2):djt430.CrossRef
103.
go back to reference Kucuk O, Sarkar FH, Sakr W, et al. Phase 2 randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomark Prev. 2001;10:861–8.
Kucuk O, Sarkar FH, Sakr W, et al. Phase 2 randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomark Prev. 2001;10:861–8.
104.
go back to reference Vecchia L, Negri E, D’Avanzo B, et al. Tea consumption and cancer risk. Nutr Cancer. 1992;17:27–31.PubMedCrossRef
Vecchia L, Negri E, D’Avanzo B, et al. Tea consumption and cancer risk. Nutr Cancer. 1992;17:27–31.PubMedCrossRef
105.
go back to reference Wang P, Aronson WJ, Huang M, et al. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res. 2010;3:985–93.CrossRef
Wang P, Aronson WJ, Huang M, et al. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res. 2010;3:985–93.CrossRef
106.
go back to reference Kurahashi N, Sasazuki S, Iwasaki M, et al. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 2008;167:71–7.PubMedCrossRef
Kurahashi N, Sasazuki S, Iwasaki M, et al. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 2008;167:71–7.PubMedCrossRef
107.
go back to reference Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk. A review of the epidemiological evidence. Nutrition and Cancer. 2002;42:1–9.PubMedCrossRef
Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk. A review of the epidemiological evidence. Nutrition and Cancer. 2002;42:1–9.PubMedCrossRef
108.
go back to reference Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomark Prev. 2003;12:1403–9.
Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomark Prev. 2003;12:1403–9.
109.
go back to reference Kirsh VA, Peters U, Mayne ST, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007;99:1200–9.PubMedCrossRef
Kirsh VA, Peters U, Mayne ST, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007;99:1200–9.PubMedCrossRef
110.
go back to reference Freedland SJ, Carducci M, Kroeger N, et al. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev Res. 2013;6:1120–7.CrossRef
Freedland SJ, Carducci M, Kroeger N, et al. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev Res. 2013;6:1120–7.CrossRef
111.
go back to reference Stenner-Liewen F, Liewen H, Cathomas R, et al. Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer – results of a phase 2b randomized controlled trial. J Cancer. 2013;4:597–605.PubMedPubMedCentralCrossRef
Stenner-Liewen F, Liewen H, Cathomas R, et al. Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer – results of a phase 2b randomized controlled trial. J Cancer. 2013;4:597–605.PubMedPubMedCentralCrossRef
112.
go back to reference Pantuck AJ, Pettaway CA, Dreicer R, et al. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015;18:242–8.PubMedCrossRef
Pantuck AJ, Pettaway CA, Dreicer R, et al. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015;18:242–8.PubMedCrossRef
113.
go back to reference Chan R, Lok K, Woo J. Prostate Cancer and vegetable consumption. Mol Nutr Food Res. 2009;53:201–16.PubMedCrossRef
Chan R, Lok K, Woo J. Prostate Cancer and vegetable consumption. Mol Nutr Food Res. 2009;53:201–16.PubMedCrossRef
114.
go back to reference Zhou XF, Ding ZS, Liu NB. Allium vegetables and risk of prostate cancer: evidence from 132,192 subjects. Asian Pac J Cancer Prev. 2013;14:4131–4.PubMedCrossRef
Zhou XF, Ding ZS, Liu NB. Allium vegetables and risk of prostate cancer: evidence from 132,192 subjects. Asian Pac J Cancer Prev. 2013;14:4131–4.PubMedCrossRef
115.
go back to reference Zhang Q, Zhao Q, Shen Y, et al. Allium vegetables, garlic supplements, and risk of cancer: a systematic review and meta-analysis. Front Nutr. 2022;8:746944.PubMedPubMedCentralCrossRef
Zhang Q, Zhao Q, Shen Y, et al. Allium vegetables, garlic supplements, and risk of cancer: a systematic review and meta-analysis. Front Nutr. 2022;8:746944.PubMedPubMedCentralCrossRef
116.
go back to reference Asemani Y, Zamani N, Bayat M, et al. Allium vegetables for possible future of cancer treatment. Phytother Res. 2019;33:3019–39.PubMedCrossRef
Asemani Y, Zamani N, Bayat M, et al. Allium vegetables for possible future of cancer treatment. Phytother Res. 2019;33:3019–39.PubMedCrossRef
117.
go back to reference Hsing AW, Chokkalingam AP, Gao YT, et al. Allium vegetables and the risk of prostate cancer: A population-based study. J Natl Cancer Inst. 2002;94:1648–51.PubMedCrossRef
Hsing AW, Chokkalingam AP, Gao YT, et al. Allium vegetables and the risk of prostate cancer: A population-based study. J Natl Cancer Inst. 2002;94:1648–51.PubMedCrossRef
118.
go back to reference Termini D, Den Hartogh DJ, Jaglanian A, et al. Curcumin against prostate cancer: current evidence. Biomolecules. 2020;10:1536.PubMedPubMedCentralCrossRef
Termini D, Den Hartogh DJ, Jaglanian A, et al. Curcumin against prostate cancer: current evidence. Biomolecules. 2020;10:1536.PubMedPubMedCentralCrossRef
119.
go back to reference Jordan BC, Mock CD, Thilagavathi R, et al. Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sci. 2016;152:135–44.PubMedPubMedCentralCrossRef
Jordan BC, Mock CD, Thilagavathi R, et al. Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sci. 2016;152:135–44.PubMedPubMedCentralCrossRef
120.
go back to reference Hong JH, Lee G, Choi HY. Effect of curcumin interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts. Korean J Urol. 2015;56:656–65.PubMedPubMedCentralCrossRef
Hong JH, Lee G, Choi HY. Effect of curcumin interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts. Korean J Urol. 2015;56:656–65.PubMedPubMedCentralCrossRef
121.
go back to reference Yang J, Ning J, Peng L, et al. Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer. Clin J Clin Exp Pathol. 2015;8:9272–8.
Yang J, Ning J, Peng L, et al. Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer. Clin J Clin Exp Pathol. 2015;8:9272–8.
122.
go back to reference Thangavel S, Yoshitomi T, Sakharkar NK, et al. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer. J Control Release. 2015;209:110–9.PubMedCrossRef
Thangavel S, Yoshitomi T, Sakharkar NK, et al. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer. J Control Release. 2015;209:110–9.PubMedCrossRef
123.
go back to reference Gupta N, Patel HD, Taylor J, et al. Systematic review of the impact of plant-based diet on prostate cancer incidence and outcomes. Prostate Cancer Prostatic Dis. 2022;25:444–52.PubMedCrossRef
Gupta N, Patel HD, Taylor J, et al. Systematic review of the impact of plant-based diet on prostate cancer incidence and outcomes. Prostate Cancer Prostatic Dis. 2022;25:444–52.PubMedCrossRef
124.
go back to reference Shin J, Millstine D, Ruddy B, et al. Effect of plant- and animal-based food on prostate cancer risk. J Am Osteopath Assoc. 2019;119:736–46.
Shin J, Millstine D, Ruddy B, et al. Effect of plant- and animal-based food on prostate cancer risk. J Am Osteopath Assoc. 2019;119:736–46.
125.
go back to reference La Vignera S, Basile L. Diet and prostate health: an underrated tool? Aging Male. 2022;25(1):67–71.CrossRef
La Vignera S, Basile L. Diet and prostate health: an underrated tool? Aging Male. 2022;25(1):67–71.CrossRef
126.
go back to reference Tantamango-Bartley Y, Knutsen SF, Knutsen R, et al. Are strict vegetarians protected against prostate cancer? Am J Clin Nutr. 2016;103:153–60.PubMedCrossRef
Tantamango-Bartley Y, Knutsen SF, Knutsen R, et al. Are strict vegetarians protected against prostate cancer? Am J Clin Nutr. 2016;103:153–60.PubMedCrossRef
127.
go back to reference Lin PH, Aronson W, Freedland SJ. An update of research evidence on nutrition and prostate cancer. Urol Oncol Seminars Original Inv. 2019;37:387–401.
Lin PH, Aronson W, Freedland SJ. An update of research evidence on nutrition and prostate cancer. Urol Oncol Seminars Original Inv. 2019;37:387–401.
Metadata
- Title
- The Impact of Diet and Nutrition on Prostate Cancer – Food for Thought?
- Authors
-
Rodrick Babakhanlou
Krisstina Gowin
- Publication date
- 15-02-2025
- Publisher
- Springer US
- Published in
-
Current Oncology Reports
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269 - DOI
- https://doi.org/10.1007/s11912-025-01641-x
Image Credits
Healthy food/© fcafotodigital / Getty Images / iStock, Aplastic Anemia/© Springer Healthcare IME, CAR T-cell attacking cancer cells/© Springer Medicine, June 2024, under a creative commons [CCBY] license.